Silica nanoparticles trigger hepatic lipid-metabolism disorder in vivo and in vitro

BACKGROUND: As a promising nanocarrier in biomedical fields, silica nanoparticles (SiNPs) could transfer from the circulatory system to multiple organs. Among these, blood–liver molecular exchange is a critical factor in biological response to NPs. However, the potential effect of SiNPs on hepatic l...

Descripción completa

Detalles Bibliográficos
Autores principales: Duan, Junchao, Liang, Shuang, Feng, Lin, Yu, Yang, Sun, Zhiwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6233484/
https://www.ncbi.nlm.nih.gov/pubmed/30519016
http://dx.doi.org/10.2147/IJN.S185348

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6233484/
https://www.ncbi.nlm.nih.gov/pubmed/30519016
http://dx.doi.org/10.2147/IJN.S185348

Ejemplares similares